M. Lejeune

Impact of Cotransplantation of Mesenchymal Stem Cells on Lung Function After Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Following Non-Myeloablative Conditioning

F. Baron, R. Louis, L. Seidel, 2014, Transplantation.

Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long‐term survival

F. Baron, L. Seidel, Y. Beguin, 2015, American journal of hematology.

COVID-19, impact on myeloma patients

M. Vekemans, A. Kentos, M. Delforge, 2020, Annals of Hematology.

Three-Year Follow-up of Biomicroscopy Signs and Refractive Status in Patients Wearing Lotrafilcon A Lenses

F. Malet, B. Long, R. Pagot, 2005, Eye & contact lens.

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.

F. Baron, G. Fillet, L. Seidel, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study.

D. Blockmans, B. van Houdenhove, H. Bobbaers, 2003, The American journal of medicine.

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium

Z. Berneman, G. Verhoef, K. van Eygen, 2019, Acta Haematologica.

Distinction of Lymphoma from Sarcoidosis on 18F-FDG PET/CT: Evaluation of Radiomics-Feature–Guided Machine Learning Versus Human Reader Performance

Patrick E. Meyer, R. Hustinx, N. Withofs, 2022, The Journal of Nuclear Medicine.

The Case | An unusual cause of renal vascular thrombi after kidney transplantation.

F. Jouret, A. Bouquegneau, C. Bovy, 2022, Kidney international.

[Iodine 131 uptake by a bronchogenic cyst in a patient with differentiated carcinoma of the thyroid gland].

J. Luton, C. Heron, A. Louvel, 2000, Presse medicale.

Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.

F. Baron, G. Fillet, L. Seidel, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.